NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NYSE · Medical Instruments & Supplies · USD

ResMed Inc. (RMD) Stock Analysis

ResMed Inc. (RMD) is a Medical Instruments & Supplies stock listed on NYSE and quoted in US Dollar.

Last Updated: October 21, 2026

RMD

$246.20

+$0.70 (+0.29%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RMD with… →

RMD Key Statistics

As of Oct 21, 2026
Trading
Open
$243.94
Previous Close
$245.50
Day's Range
244.38–248.60
52-Week Range
180.27–277.67
Volume
873.49K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.75
Valuation
Market Cap
$34.63B
P/E Ratio
23.60
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
18.61
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.42
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
6.12
EPS (ttm)Profit attributable to each share over the last twelve months.
10.43
Financials (FY)
Revenue (FY)
$5.15B+9.84%
Net Income (FY)
$1.40B+37.20%
Profit marginThe share of revenue left as profit after all costs and taxes.
26.95%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
140.64M
1-Year Return
−7.24%
Dividend and dates
Dividend
$2.64+1.08%
Ex-Dividend Date
August 20, 2026
Earnings Date
October 29, 2026
Avg Volume
1.31M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, RMD closed at $246.20, −7.24% over 1 year.

ResMed Inc. (RMD) has a market capitalization of $34.63B.

In fiscal 2025, RMD reported revenue of $5.15B.

RMD Stock Return by Calendar Year

ResMed Inc. (RMD) 10-year return: what $10,000 became

1 year
$10,000 $9,276
−7.24%
5 years
$10,000 $9,795
−2.05%
10 years
$10,000 $43,162
+331.62%

If you had invested $10,000 in ResMed Inc. (RMD) 10 years ago, at the close on October 21, 2016, it would have been worth $43,162 at the close on October 21, 2026: +331.62% in total, +15.75% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+3.05%
2025+6.26%
2024+34.18%
2023−16.55%
2022−19.47%
2021+23.41%
2020+38.33%
2019+37.85%
2018+36.38%
2017+39.06%
2016 (partial year)−11.41%

As of October 21, 2026.

RMD Revenue and Earnings by Fiscal Year

FY ends June
Fiscal yearRevenueNet incomeNet margin
2025$5.15B$1.40B27.2%
2024$4.69B$1.02B21.8%
2023$4.22B$897.56M21.3%
2022$3.58B$779.44M21.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$5.15B$3.05B$1.69B$1.40B27.2%
2024$4.69B$2.66B$1.38B$1.02B21.8%
2023$4.22B$2.36B$1.15B$897.56M21.3%
2022$3.58B$2.02B$1.00B$779.44M21.8%

Annual figures as reported, in the company's reporting currency. As of June 30, 2025.

RMD Dividend History

$2.26+11.9% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.863—
2025$2.264+11.9%
2024$2.024+9.8%
2023$1.844+7.0%
YearDividends per sharePaymentsChange
2026 (partial year)$1.863—
2025$2.264+11.9%
2024$2.024+9.8%
2023$1.844+7.0%
2022$1.724+6.2%
2021$1.624+3.8%
2020$1.564+2.6%
2019$1.524+5.6%
2018$1.444+5.9%
2017$1.364+312.1%
2016$0.331—

Most recent payment: $0.62 per share, ex-dividend August 20, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

RMD Valuation vs Medical Instruments & Supplies Median

Median of 50 stocks
MetricRMDMedical Instruments & Supplies medianvs median
P/E23.6031.1924% below
P/S ratio6.122.60136% above
Profit margin26.95%1.62%25.3 pts above

Medians across 50 Medical Instruments & Supplies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values ResMed Inc. (RMD) at $34.63B. It is classified in the Medical Instruments & Supplies industry, within the Healthcare sector. Headcount on file is 11,370.

The most recent close on file for RMD is $246.20, dated October 21, 2026. That is +$0.70 (+0.29%) against the previous close. The 52-week range on file runs from $180.27 to $277.67. The latest close sits 36.57% above that 52-week low.

Financial Health

In fiscal 2025, ResMed Inc. reported revenue of $5.15B. That is +9.84% against the prior fiscal year, when revenue was $4.69B. Net income for the same year was $1.40B. That is +37.20% against the prior fiscal year. The reported profit margin is 26.95%. That is 25.3 percentage points above the Medical Instruments & Supplies median of 1.62%. Trailing earnings per share are 10.43.

Across the 4 fiscal years on file, revenue moves from $3.58B in 2022 to $5.15B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 23.6. That is 24.33% below the Medical Instruments & Supplies median of 31.19. The forward P/E on file is 18.61. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.42. The price-to-sales ratio is 6.12. On price-to-sales that is 135.77% above the Medical Instruments & Supplies median of 2.6. 50 Medical Instruments & Supplies companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −7.24%. Measured over 10 years, that is +15.75% a year compounded. The reported beta is 0.75. Daily returns over the trailing 10 years annualize to a volatility of 31.87%.

Growth & Income

The trailing dividend yield is 1.08%. At the indicated rate that is $2.64 a share a year. The ex-dividend date on file is August 20, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.86 a share. The year before, 2025, totalled $2.26 a share.

Across the complete calendar years on file, 2017 returned +39.06% and 2022 returned −19.47%. Of the 9 complete calendar years on file, 7 finished higher. So far in 2026 the total return is +3.05%.

Peer Comparison

ResMed Inc. (RMD) operates in the Medical Instruments & Supplies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
ResMed Inc. RMD $34.63B 23.6
Intuitive Surgical, Inc. ISRG $151.25B 51.8
Becton, Dickinson and Company BDX $52.79B 45.1
Medline Inc. MDLN $47.51B 88.3

The Medical Instruments & Supplies industry average P/E ratio is 31.2x. ResMed Inc. trades at a P/E of 23.6.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Instruments & Supplies Stocks

ISRG

Intuitive Surgical, Inc.

$151.25B

 BDX

Becton, Dickinson and Company

$52.79B

 MDLN

Medline Inc.

$47.51B

 ALC

Alcon Inc.

$32.60B

 WST

West Pharmaceutical Services, Inc.

$27.69B

 SOLV

Solventum Corporation

$14.75B
View all Medical Instruments & Supplies stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About ResMed Inc.

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Visit website →